Table 7.
Cases/Controls | Studies included | Endpoint | OR (95% CI)a | I-squared | Notes | |
---|---|---|---|---|---|---|
FVL | ||||||
Marjot, 2011 [146] | 767/4020 | 19 | CVTb | 2.40 (1.75-3.30) | 0.0% | Adults, European descent |
Gohil, 2009 [4] | 22225/37566 | 84 | VTEc | 4.93 (4.41-5.52) | 58.0% | Studies from European/American authors |
PT20201A | ||||||
Marjot, 2011 [146] | 646/3690 | 15 | CVT | 5.48 (3.88-7.74) | 0.0% | Adults, European descent |
Gohil, 2009 [4] | 21605/27947 | 79 | VTE | 3.17 (2.19-3.46) | 0.0% | Studies from European/American authors |
Gohil, 2009 [4] | 546/1734 | 4 | VTE | ncd | nc | Studies from Asian authors PT20201A not found |
MTHFR C677T | ||||||
Marjot, 2011 [146] | 233/1323 | 7 | 1.97 | 1.83 (0.88-3.80) | 68.0% | Adults, European descent |
Gouveia, 2010 [147] | 382/1217 | 9 | 5.48 | 1.12 (0.80-1.58) | 60.5% | - |
Gohil, 2009 [4] | 13570/20935 | 50 | nc | 1.57 (1.23-2.0) | 60.0% | Studies from European/American authors |
Gohil, 2009 [4] | 827/2758 | 12 | nc | 1.09 (0.97-1.24) | 0.0% | Studies from Asian authors |
Odds ratio, 95% Confidence intervals
Cerebral venous thrombosis
Venous thromboembolism
Not computable